| Evaluation of the Effectiveness of the Ezisurg Stapling (Ezi Endo Lite) During Laparoscopic Nissen Sleeve Gastrectomy (NCT07344935) | Ezisurg Medical Co. Ltd. | 2022-01-01 |
| Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone (NCT04130659) | Nekkar Lab Srl | 2019-08-08 |
| Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) (NCT03561883) | Ironwood Pharmaceuticals, Inc. | 2018-09-06 |
| Efficacy and Safety of DLBS2411 in the Management of GERD (NCT03367195) | Dexa Medica Group | 2018-08-16 |
| Retrospective Observational Study on GERD Management in General Hospitals in Korea (NCT06974903) | Chong Kun Dang Pharmaceutical | 2018-01-03 |
| Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication (NCT06862037) | Korea University Anam Hospital | 2017-02-01 |
| An Investigation of the EndoStim® Lower Esophageal Sphincter (LES) Stimulation System for the Treatment of Reflux (NCT02749071) | EndoStim Inc. | 2016-05-01 |
| The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity (NCT02689999) | Neutec Ar-Ge San ve Tic A.Ş | 2016-02-01 |
| Experimental Study to Determine the Effects of Human Refluxate on Macrophage Phenotype and Its Correlation With GERD (NCT02699060) | Ivashkin Vladimir Trofimovich | 2016-02-01 |
| Medigus Ultrasonic Surgical Endostapler (MUSE) Registry (NCT02366169) | Medigus Ltd | 2015-03-01 |
| Indiana University Gastrointestinal Motility Diagnosis Registry (NCT04506593) | Indiana University | 2014-11-01 |
| Mucosal Impedance in Pediatric Population (NCT02320981) | Vanderbilt University Medical Center | 2014-08-01 |
| Assessment of Esophageal Epithelium Integrity With Mucosal Impedance (NCT02318862) | Vanderbilt University Medical Center | 2013-07-01 |
| Response to Supplement and Placebo in GERD (NCT01915173) | Beth Israel Deaconess Medical Center | 2013-06-01 |
| A Post-Approval Study of the LINX® Reflux Management System (NCT01940185) | Torax Medical Incorporated | 2012-06-30 |
| The EndoGastric Solutions TEMPO Trial (NCT01647958) | EndoGastric Solutions | 2012-06-01 |
| Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury (NCT01570842) | Mayo Clinic | 2011-10-01 |
| RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol (NCT01406210) | Duke University | 2011-09-01 |
| Proton Pump Inhibitors and Risk of Community-acquired Pneumonia (NCT02555852) | Canadian Network for Observational Drug Effect Studies, CNODES | 2011-09-01 |
| Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus? (NCT01373125) | University of North Carolina, Chapel Hill | 2011-06-01 |
| Racial Disparity in Barrett's Esophagus (NCT01374074) | University of North Carolina, Chapel Hill | 2011-03-01 |
| Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study (NCT01327963) | EndoGastric Solutions | 2010-09-01 |
| To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use (NCT01306799) | University of Pennsylvania | 2010-01-01 |
| Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD (NCT01025739) | University of Alberta | 2010-01-01 |
| Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis (NCT01389401) | Faculdade de Ciências Médicas da Santa Casa de São Paulo | 2009-01-01 |
| A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients (NCT00787891) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-01-01 |
| Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux (NCT01091805) | Wake Forest University Health Sciences | 2008-12-01 |
| Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US (NCT00795093) | AstraZeneca | 2008-11-01 |
| TAK-438 - Safety, Blood Levels & Effects of Repeated Doses (NCT02141711) | Takeda | 2008-10-01 |
| Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) (NCT00838526) | Eisai Inc. | 2008-08-31 |
| Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) (NCT00839306) | Eisai Inc. | 2008-08-01 |
| Safety and Efficacy the Medigus SRS Endoscopic Stapling System in Gastroesophageal Reflux Disease (GERD) (NCT00734747) | Aviel Roy-Shapira, M.D. | 2008-05-01 |
| Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) (NCT00658528) | Eisai Inc. | 2008-02-01 |
| Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) (NCT00658632) | Eisai Inc. | 2008-02-01 |
| Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) (NCT00658775) | Eisai Inc. | 2008-02-01 |
| A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive (NCT00747526) | Janssen Research & Development, LLC | 2007-12-01 |
| Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI (NCT00587275) | Ocera Therapeutics | 2007-10-01 |
| Optimal Dosing of Omeprazole in Neonates (NCT01657578) | Assistance Publique - Hôpitaux de Paris | 2007-06-01 |
| Phase 3/Safety & Efficacy of Esomeprazole in Infants (NCT00468559) | AstraZeneca | 2007-04-01 |
| Symptom Improvements in Gastroesophageal Reflux Disease (GERD) Patients (NCT00394472) | AstraZeneca | 2006-11-01 |
| Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) (NCT00312806) | Takeda | 2006-05-01 |
| A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD (NCT00575822) | NDO Surgical, Inc. | 2005-01-01 |
| Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter Results (NCT00587392) | NDO Surgical, Inc. | 2004-12-01 |
| Esomeprazole for Treatment of GERD in Pediatric Patients (NCT00228527) | AstraZeneca | 2004-10-01 |
| Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients (NCT00241501) | AstraZeneca | 2004-02-01 |
| Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). (NCT00171483) | Novartis | 2004-01-01 |
| Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients (NCT00574925) | University of Zurich | 2003-11-01 |
| Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs). (NCT00171418) | Novartis | 2003-06-01 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD) (NCT00628342) | AstraZeneca | 2003-04-01 |
| Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) (NCT00261300) | Takeda | 2000-10-01 |
| Esophageal Cancer Risk Registry (NCT00260585) | University of Pittsburgh | 1999-06-01 |
| A Study on the Effectiveness of Laparoscopic Fundoplication on Extraesophageal Manifestations of Gastroesophageal Reflux Disease (GERD) (NCT01324986) | General Public Hospital Zell am See | |